Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has gained attention for its potential to reduce smoking cravings alongside weight loss. Recent observational studies indicate that patients using semaglutide report fewer cigarettes smoked per day and lower urges to light up. While semaglutide is not an FDA-approved smoking cessation medication, its mechanism of action on dopamine and reward circuits may offer unexpected benefits for smokers trying to quit.

How Semaglutide May Affect Smoking Behavior

Semaglutide works by activating GLP-1 receptors throughout the brain, including regions that regulate reward, impulse control, and cravings. Nicotine addiction involves the same dopamine pathways that semaglutide influences, which may explain why some patients report reduced smoking urges after starting the medication. The drug's effects on appetite suppression and mood stabilization can reduce the emotional triggers—stress, boredom, and overeating—that often accompany quit attempts.

A 2023 observational report from a weight loss clinic found that 40% of semaglutide patients who smoked reduced their cigarette consumption within three months, even though smoking cessation was not a stated treatment goal. These findings remain preliminary and were not from a randomized controlled trial, but they suggest a genuine biological link between GLP-1 activation and reduced nicotine dependence behavior.

Semaglutide vs. Traditional Smoking Cessation Medications

Conventional smoking cessation treatments like varenicline (Chantix) and bupropion (Wellbutrin) target nicotine receptors and norepinephrine pathways directly, while semaglutide is an indirect approach that modulates appetite and reward circuits. Semaglutide is not a replacement for FDA-approved smoking cessation therapies and should not be used as a standalone quit-smoking tool. However, patients who need weight management and are motivated to quit smoking may benefit from combining semaglutide with evidence-based cessation strategies like counseling, nicotine replacement therapy, or prescription cessation medications.

One key advantage of semaglutide for dual-goal patients is that it addresses both smoking-related weight gain and metabolic health without the neurological side effects reported in some varenicline users. Unlike nicotine replacement patches, semaglutide does not deliver nicotine and therefore does not maintain addiction; instead, it may reduce the behavioral and emotional dependency on smoking.

Genetic Factors in Smoking Cessation and GLP-1 Response

PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and identifies variants in the GLP1R gene (rs6923761) and MC4R gene (rs17782313) that influence how strongly an individual's brain responds to GLP-1 activation. These genetic insights reveal whether a patient's reward and appetite pathways are naturally sensitive to semaglutide, which may predict not only weight loss effectiveness but also the likelihood of reduced smoking urges. Patients with high-sensitivity GLP1R variants may experience stronger dopamine modulation and greater craving reduction.

The FTO gene variant (rs9939609) also plays a role in both obesity risk and addictive behavior patterns. Understanding your genetic predisposition to nicotine dependence and reward-seeking behavior can help PlexusDx providers personalize your semaglutide dose and counsel you on realistic expectations for smoking reduction during treatment.

Using Compounded Semaglutide Safely While Quitting Smoking

PlexusDx compounded semaglutide injection is prepared by licensed 503A compounding pharmacies and available in all 50 states without insurance, starting at $149 per month. If you are actively trying to quit smoking while using semaglutide, inform your PlexusDx clinical team so they can monitor your progress, adjust your dose as needed, and coordinate with any other cessation medications or counseling you are using. Your dose may need to go up; your price won't.

Semaglutide can cause mild nausea and appetite loss, which some patients find helpful for reducing post-quit snacking but which may complicate early quit attempts if they overlap with nicotine withdrawal symptoms. Starting at a low dose and titrating gradually gives your body time to adapt while you focus on the behavioral and psychological work of smoking cessation. HSA and FSA accounts can cover PlexusDx semaglutide, making it more affordable for patients pursuing multiple health goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I use semaglutide as my only smoking cessation medication?

No. Semaglutide is not FDA-approved for smoking cessation and should not replace evidence-based quit-smoking treatments like varenicline, bupropion, nicotine replacement, or counseling. However, PlexusDx semaglutide may complement these therapies if you also need weight management and are motivated to quit. Always discuss your smoking cessation plan with a healthcare provider.

What does the research say about semaglutide and smoking?

Observational studies and patient reports suggest semaglutide users may reduce cigarette consumption, likely due to effects on dopamine and reward pathways. However, no large randomized controlled trials have yet examined semaglutide as a smoking cessation therapy. More rigorous research is needed before semaglutide can be recommended specifically for quitting smoking.

How much does PlexusDx compounded semaglutide cost, and is it covered by insurance?

PlexusDx semaglutide injection starts at $149 per month and does not require insurance—PlexusDx serves all 50 states directly. Your dose may need to go up, but your price stays the same. HSA and FSA accounts are eligible, lowering your out-of-pocket cost.

Are there side effects I should watch for if I'm using semaglutide and quitting smoking at the same time?

Semaglutide can cause nausea, reduced appetite, and mild gastrointestinal changes, while nicotine withdrawal may cause irritability, anxiety, and cravings. These symptoms can overlap and magnify stress during early quit attempts. Working with a PlexusDx provider and a smoking cessation counselor helps separate which symptoms come from which source and guides dose adjustments.

Can PlexusDx genetic testing predict whether semaglutide will help me stop smoking?

The PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) maps your GLP1R, MC4R, and FTO variants to show how sensitively your brain responds to GLP-1 activation. Higher sensitivity predicts stronger effects on dopamine and reward circuits, which may correlate with reduced smoking urges. This personalized insight helps your PlexusDx provider optimize your dose and set realistic expectations for dual benefits: weight loss and possible smoking reduction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves